The Merck Group is in the process of repositioning itself.
Recommended by Merck KGaA, what is your first reaction? A long-established pharmaceutical company? In fact, since 2015, Merck has launched the company’s new brand identity, a new visual image that is eye-catching and vibrant – The Merck Group is transforming itself and repositioning itself.
In the days that follow, you need to re-recognize Merck, and by increasing the number of medical health, life sciences, and high-performance materials, it is becoming a a vibrant global technology company >. Although Merck is separated from the consumer market by many links, the computers, smart phones, and LCD screens you use are all related to it. Only for the statistics of the China Semiconductor Industry Association, Merck holds 50% of the global mixed crystal market. Share, ranking first in the world.
Not only that, Merck China has a history of 86 years of exploration. The Chinese market, which shows the Technology Business Unit (which is a high-performance materials business) and the General Drugs and Endocrinology Division (which is a pharmaceutical health business), has also become Merck’s largest market in the world. China’s innovation environment and rapid development provide a common opportunity for growth for Merck and its partners. As an important part of the global strategy, Merck is constantly strengthening its production, research and development efforts and investment in innovation in the Chinese market. In October 2018, the Merck China Innovation Center officially launched the first phase of China Accelerator Project Recruitment, and through the link to Merck’s internal business resources and external startups, to achieve integration and innovation, and further promote the development of innovative projects in China.
For startups, this is an opportunity to get in touch with Merck’s more than 350 years of accumulated business, renew its expertise and innovative models; for Merck, this is the best solution for cutting-edge technology and innovative ideas. In turn, it drives the power of innovation from the inside out. Ms. Sun Zhengjie, Managing Director of Merck China Innovation Center and Vice President of Strategy and Transformation at Merck China, said,
As a technology company, we want to leverage our technology and R&D to benefit our customers in all areas and businesses. In the medical and health sector, we focus on neurology, oncology, and immuno-oncology, with 80% of products in these three areas of focus. In life sciences, one of our priorities is to promote the use of new technologies in new therapies, such as gene editing technology. In terms of high performance materials, we are